Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pharma and Biotech Professionals of CEE Getting Together for Further Industry Growth in the Region

Published: Friday, January 18, 2013
Last Updated: Friday, January 18, 2013
Bookmark and Share
PHARM Connect Congress has been established to facilitate the collaboration and development of the most important pharma and biotech players.

Central and Eastern Europe is a rapidly emerging market for pharmaceutical manufacturing and distribution, and at the same time countries of the region are becoming hot-spots for research with many universities, research institutes and biotechnology companies being present. On the other hand, companies in the pharmaceutical sector face challenges that are not encountered in any other, from healthcare reforms to changing regulations. It is clear that in these sectors the constant search for effective and innovative partnerships as well as continuous professional development and market-specific knowledge are more important than in any other field.

Responding to the demand of a growing industry with exceptionally specific needs, the annual PHARM Connect Congress has been established to facilitate the collaboration and development of the most important pharma and biotech players in the emerging and strategically important region of CEE. On 27-28 February, the most prominent professionals and the key solution providers will gather in the five-star Corinthia Grand Hotel Royal in Budapest for the third time, to discuss challenges and start new collaborations at the market-leading pharmaceutical event. With its unique format that combines professional development and effective networking, PHARM Connect is supported by all major associations and governmental ministries, who agree that the congress has developed itself into a much needed platform for further industry growth in the region.

From OPEX to logistics: the most up-to-date topics

The conference programme will cover a wide range of topics from operational excellence (Prof. Dr. Thomas Friedli from the University of St. Gallen in Switzerland) and new logistics strategies (Zoltán Kelemen, CEE Business Development Manager of Phoenix Pharma) to the new EU Pharmacovigilance legislations (Amer Alghabban, Director of Gobal Quality Assurance & Auditing at Merck). Martin Fitzgerald, Deputy Director General of the European Association of Pharmaceutical Full-line Wholesalers will explain the impact of medicines verification systems on today’s pharmaceutical supply chain, giving ideas on developing a cost-effective solution for medicines verification in Europe. The future of personalized medicines will be addressed by Dr. István Peták and Dr. Richárd Schwab, Scientific and Medical Directors of KPS Diagnostics, who will share their valuable ideas on how to make biosimilars and diagnostics more affordable. Other speakers include Dr. Zsolt Szombathelyi, the Global Research Director of Gedeon Richter, who will talk about keeping the R&D pipeline innovative and Prof. Dr. Tamás L. Paál, the Senior Adviser of GYEMSZI as the Chairman of the first day. The programme was put together with the help of a renowned advisory committee to make sure that all areas of pharmaceutical production and distribution – from R&D and quality to purchasing and logistics - are covered. As Dr. Jens Scheibner, the Executive Director of Operations Biberach at Boehringer Ingelheim put it: “the most important and up-to-date topics are covered, exactly the way it should be.“

Effective networking is the key to success

The conference is only one part of the secret recipe that makes PHARM Connect the market-leading event in CEE. During the two days the most important solution providers will exhibit their innovative products; moreover, they will host pre-scheduled one-to-one meetings with key decision makers attending the event. This is the point where one can clearly distinguish networking and effective networking: face-to-face meetings that were mutually agreed on prior to the event guarantee that delegates will be in a position to discuss their own needs based on the current and future projects within their companies. Over 30 vendors will be represented covering a wide scope of solutions from automation, APIs, lab equipment to warehousing, logistics and beyond – Aptar Pharma, Cemelog, GE Intelligent Platforms, DHL, Evonik, Festo, Fette, Phoenix Pharma, Sartorius, Menadiona, Bosch Packaging, ABB,  just to mention a few – assuring that everyone finds what they are looking for.

PHARM Connect will bring together over 500 key decision-makers of the most important pharmaceutical and biotechnology companies from at least 20 different countries of the region for two days to provide them with a platform where they can learn from their most respected peers, immerse themselves in an environment where everyone is talking about their day-to-day challenges and find solutions to them via effective meetings. The professional atmosphere will be complemented by more informal networking opportunities – like a plant excursion to the GSK Biologicals plant and a cocktail reception on the first evening – making PHARM Connect not only a truly beneficial event, but an enjoyable one as well.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PHARM Connect Congress
The first edition of the PHARM Connect Congress, held in Budapest, proved to be an outstanding success for top-level executives and has already established itself as the must-attend event for pharmaceutical and biotechnology sector professionals operating in Central and Eastern Europe.
Friday, March 18, 2011
Scientific News
Study Finds Brain Chemicals that Keep Wakefulness in Check
Researchers to develop new drugs that promote better sleep, or control hyperactivity in people with mania.
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Playing 'Tag' with Pollution lets Scientists See Who's It
Using a climate model that can tag sources of soot from different global regions and can track where it lands on the Tibetan Plateau, researchers have determined which areas around the plateau contribute the most soot — and where.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
High-Resolution 3D Images Reveal the Muscle Mitochondrial Power Grid
NIH mouse study overturns scientific ideas on energy distribution in muscle.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!